Evidence map›Paper›PMID 35307409›Full record

ArticleExperimental cell research2022

Mechanisms underlying melanoma invasion as a consequence of MLK3 loss.

Henriette U Balinda, Alanna Sedgwick, Crislyn D'Souza-Schorey

Open access · greenAbstract read
In one paragraph

Article in Experimental cell research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Henriette U BalindaDepartment of Biological Sciences, University of Notre Dame, Notre Dame, IN, 46556-0369, USA.
Alanna SedgwickDepartment of Biological Sciences, University of Notre Dame, Notre Dame, IN, 46556-0369, USA.
Crislyn D'Souza-SchoreyDepartment of Biological Sciences, University of Notre Dame, Notre Dame, IN, 46556-0369, USA. Electronic address: cdsouzas@nd.edu.
University of Notre Dame · US

Funding

Molecular Mechanisms of Cell InvasionR01CA115316 · NCI · UNIVERSITY OF NOTRE DAME · PI D'SOUZA-SCHOREY, CRISLYN · 2011 to 2016
$1.5M
NCI NIH HHS R01 CA115316
6 · The paper itself

Abstract

Invasive melanoma is an aggressive form of skin cancer with high incidence of mortality. The process of tumor invasion is a crucial primary step in the metastatic cascade, yet the mechanisms involved are still under investigation. Here we document a critical role for MLK3 (MAP3K11) in the regulation of melanoma cell invasion. We report the unexpected finding that cellular loss of MLK3 in melanoma cells promotes cell invasion. Cellular depletion of MLK3 expression results in the hyperactivation of ERK, which is linked to the formation of a BRAF/Hsp90/Cdc37 protein complex. ERK hyperactivation leads to enhanced phosphorylation and inactivation of GSK3β and the stabilization of c-Jun and JNK activity. Blocking of ERK and JNK signaling as well as Hsp90 activity downstream of MLK3-silencing significantly reduces melanoma invasion. Furthermore, ERK activation in the aforementioned context is coupled to MT1-MMP transcription as well as the TOM1L1-dependent localization of the membrane protease to invadopodia at the invasive front. These studies provide critical insight into the mechanisms that couple MLK3 loss with BRAF hyperactivation and its consequence on melanoma invasion.

Indexed as

MAP Kinase Kinase KinasesMelanomaAdaptor Proteins, Signal TransducingCell Line, TumorHSP90 Heat-Shock ProteinsHumansMAP Kinase Signaling SystemPhosphorylationProto-Oncogene Proteins B-rafAdaptor Proteins, Signal TransducingHSP90 Heat-Shock ProteinsMAP Kinase Kinase KinasesProto-Oncogene Proteins B-rafTOM1L1 protein, humanMelanomaMitogen activated protein kinase signalingMLK3Signal transductionTumor invasion

Identifiers

PMID35307409
PMCPMC9086996
OpenAlexW4221030450

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.